154 related articles for article (PubMed ID: 1364837)
1. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
Groschner K; Lindner W; Schnedl H; Kukovetz WR
Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
Nanoff C; Schütz W
J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
Greenberg S; Cantor E; Paul J
J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of diprafenone stereoenantiomers on cardiac Na+ channels.
Kohlhardt M; Fichtner H
Eur J Pharmacol; 1988 Oct; 156(1):55-62. PubMed ID: 2850211
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological effects of diprafenone, a dimethyl congener of propafenone on guinea-pig ventricular cells.
Kodama I; Suzuki R; Honjo H; Toyama J
Br J Pharmacol; 1992 Nov; 107(3):813-20. PubMed ID: 1335340
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
Wagner F; Jähnchen E; Trenk D
Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
[TBL] [Abstract][Full Text] [Related]
7. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
Stoschitzky K; Klein W; Stark G; Stark U; Zernig G; Graziadei I; Lindner W
Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749
[TBL] [Abstract][Full Text] [Related]
8. Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.
Kohlhardt M; Fichtner H
J Membr Biol; 1988 May; 102(2):105-19. PubMed ID: 2458471
[TBL] [Abstract][Full Text] [Related]
9. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
Gülker H; Heuer H; Thale J; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
[TBL] [Abstract][Full Text] [Related]
10. Interactions of the enantiomers of 3-O-methyldobutamine with alpha- and beta-adrenoceptors in vitro.
Ruffolo RR; Messick K; Horng JS
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):244-52. PubMed ID: 2991776
[TBL] [Abstract][Full Text] [Related]
11. Electromechanical effects of newly synthetized propafenone derivatives on isolated guinea-pig heart muscle preparations.
Studenik C; Lemmens-Gruber R; Heistracher P; Ecker G; Maxl A; Fleischhacker W
Arzneimittelforschung; 1996 Feb; 46(2):134-8. PubMed ID: 8720301
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres.
Delgado C; Tamargo J; Tejerina T; Valenzuela C
Br J Pharmacol; 1987 Mar; 90(3):575-82. PubMed ID: 2882804
[TBL] [Abstract][Full Text] [Related]
13. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
14. The beta 1- and beta 2-adrenoceptor affinity and beta 1-blocking potency of S- and R-metoprolol.
Wahlund G; Nerme V; Abrahamsson T; Sjöquist PO
Br J Pharmacol; 1990 Mar; 99(3):592-6. PubMed ID: 1970503
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
Ledda F; Mantelli L; Manzini S; Amerini S; Mugelli A
J Cardiovasc Pharmacol; 1981; 3(6):1162-73. PubMed ID: 6173515
[TBL] [Abstract][Full Text] [Related]
16. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
17. Diprafenone.
Drugs R D; 1999 Apr; 1(4):301-3. PubMed ID: 10566049
[No Abstract] [Full Text] [Related]
18. Comparison of enantiomers of SPFF, a novel beta2-Adrenoceptor agonist, in bronchodilating effect in guinea pigs.
Hao Z; Zhang Y; Pan L; Su X; Cheng M; Wang M; Zhao H; Wu Y
Biol Pharm Bull; 2008 May; 31(5):866-72. PubMed ID: 18451509
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor antagonist activities and binding affinities of timolol enantiomers in rat atria.
Karhuvaara S; Kaila T; Huupponen R
J Pharm Pharmacol; 1989 Sep; 41(9):649-50. PubMed ID: 2573714
[TBL] [Abstract][Full Text] [Related]
20. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
